0001513162-16-000913.txt : 20160718 0001513162-16-000913.hdr.sgml : 20160718 20160718080026 ACCESSION NUMBER: 0001513162-16-000913 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160714 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20160718 DATE AS OF CHANGE: 20160718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMERICA INC CENTRAL INDEX KEY: 0000073290 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 952645573 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08765 FILM NUMBER: 161770710 BUSINESS ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9496452111 MAIL ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19871130 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19830216 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC DATE OF NAME CHANGE: 19720508 8-K 1 form8k.htm FORM 8-K FORM 8K

SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C.


FORM 8-K


CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934



_____             July 14, 2016_________

Date of Report (date of earliest event reported)



BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

0-8765

95-2645573

(State or Other                  (Commission                  (IRS Employer
Jurisdiction of File Number) Identification Number)
Incorporation


 

17571 Von Karman Ave.

Irvine, California 92614

(Address of Principal Executive Offices

Including Zip Code)



949-645-2111

(Registrant’s Telephone Number,

Including Area Code)


______________

(Former Name or Former Address if Changed

Since Last Report)


Page 1 of 2 pages








Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers


     On July 14, 2016, the Board of Directors of Biomerica, Inc., (the “Company”) unanimously approved a resolution to increase the size of the Board of Directors from five to six members and elected Mark A. Sirgo, Pharm.D., to serve as a director of the Company. The Board of Directors of the Company also voted that Dr. Sirgo will receive an option grant of 35,000 shares of our common stock which option grant vests one-quarter on July 14, 2017 and one-quarter on each yearly anniversary thereafter of the grant. The option grant will have a ten year term.











SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated:  July 15, 2016

                        Biomerica, Inc.


            By: /s/ Zackary S. Irani

Zackary S. Irani

Chief Executive Officer